Breaking News

What was the best piece of medical writing you read this year?

December 17, 2023
Editor, First Opinion

I'm in denial that 2023 is coming to an end. I still haven't finished my holiday shopping! And my inbox is filling up with submissions from people who want to write predictions for 2024. I am not interested in prediction pieces unless the authors are also willing to look back on those articles at the end of the year, too — and people generally don't want to do that. 

But I am interested in what works of health/medical writing you read and loved this past year. What was the best book? The best piece of opinion writing? Longform article? What was the best podcast you listened to? Heck, what's the best health care TikTok you watched? I'd love to hear from you and then share some of the responses in the First Opinion newsletter next week, which will be the last one of 2023. 

This (very busy) week on First Opinion: Kate Cox is far from the first woman who wasn't helped by medical exceptions in states with abortion restrictions, Abigail Wilpers writes in a heartbreaking piece. Romila Santra, a first-year medical student, argues that medical schools are failing to teach future doctors about treating patients with intellectual and developmental disabilities. Jeffrey Millstein says it's time to rethink Medicare's annual wellness visit. American Society of Hematology President Robert Brodsky writes that there's a shortage of adult hematologists, which will make it harder for patients to access new gene therapies for sickle cell disease. Every community should have a sobering center where people can recover from intoxication and gain access to recovery support. The risk-taker behind the Dana Farber Cancer Institute's breakup with Brigham & Women's Hospital. ReproductiveRights.gov needs a complete overhaul. European countries' lessons for the U.S. on weight-loss drug coverage. The Supreme Court must affirm the FDA's authority in the upcoming case on mifepristone. The Biden administration's bad move on march-in rights. The World Health Organization's delay in declaring noma a neglected tropical disease is part of a long-time medical-dental disconnect. And on a particularly great episode of the "First Opinion Podcast," if I do say so myself, I spoke with Manil Suri and Daniel Morgan about their recent essay on the mathematical limits of diagnostic tests for rare diseases. 

Recommendation of the week: Last weekend, I binged "Believe in Magic," a BBC podcast about a teenage girl with cancer who started a charity to give great experiences to other sick young people. It raised enormous amounts of money and received a great deal of attention from celebrities, particularly members of One Direction. And then everything went very wrong. Parts of the story are familiar, but the particulars are absolutely absorbing. 

The Travis County 459th District Court is seen prior to an emergency hearing in Cox v. Texas in Austin on Dec. 7. Kate Cox, a 31-year-old mother of two from Dallas-Fort Worth, sued the state of Texas on Dec. 5 in order to get an abortion for a pregnancy that she and her doctors say threatens her life and future fertility.
SUZANNE CORDEIRO/AFP via Getty Images

Exceptions to abortion restrictions often fail people like Kate Cox whose babies are sure to die

Kate Cox's case in Texas makes it clear: Medical exceptions to anti-abortion laws don't help people whose babies are sure to die.

By Abigail Wilpers


In mifepristone case, the Supreme Court must affirm the FDA's authority. Medical innovation is at risk

Allowing judges to intervene on drug safety is not only scientifically inappropriate; it also poses a serious threat to medical innovation.

By Eva Temkin and Grace Colón


New sickle cell disease CRISPR treatments can't make up for the shortage of adult hematologists

"Any treatment patients can't access will fail to live up to its promised clinical impact," American Society of Hematology president writes.

By Robert Brodsky



Former Sens. Birch Bayh (left) and Bob Dole, the authors of the Bayh-Dole Act, in Washington in July 1985.
Wikimedia Commons/University of Kansas

The Biden administration's plan to use march-in rights to address drug prices would kill future world-changing innovations

The White House wants to use the Bayh-Dole Act — a longtime driver of inventions — to control drug prices. That's a terrible idea.

By Joseph P. Allen


The federal government fails to provide Americans with reproductive health information they need. Here's a better approach

The website ReproductiveRights.gov falls far short of the needs and expectations of the public and health care providers.

By Michael Stebbins and Eric D. Perakslis


U.S. medical schools aren't teaching future doctors about 7.4 million of their patients

There are 7.4 million Americans with intellectual and developmental disabilities. But doctors are often uncomfortable treating them.

By Romila Santra


Surgeons specializing in maxillofacial reconstructive surgery operate on a person with noma at a private clinic in Abidjan, Côte d'Ivoire.
SIA KAMBOU/AFP via Getty Images

The WHO recognizes noma after years of medical-dental disconnect

The World Health Organization's delay in recognizing noma as a neglected tropical disease is part of a global medical-dental disconnect.

By John Button


Europe's lessons for the U.S. on how to cover weight loss drugs

Reimbursement policies in Norway, the Netherlands, Poland, and Italy offer a possible path to affordable weight loss drug coverage in the U.S.

By George Hampton


Listen: When do tests hurt more than help?

On the "First Opinion Podcast," a mathematician and a physician discuss why both patients and doctors misunderstand diagnostic tests.

By Torie Bosch


A sobering unit houses up to five people who can use the space to recover from alcohol or substance use before receiving treatment at the Linn County Mental Health Access Center in Cedar Rapids, Iowa.
Rebecca F. Miller/The Gazette via AP

Sobering centers offer a safe place to recover from intoxication. Every community should have one

Sobering centers provide a safe, monitored environment for people to sober up and get help, whether on their first visit or their 12th.

By Shannon Smith-Bernardin


It's time to rethink the Medicare annual wellness visit

Incentives for primary care doctors to perform wellness visits for Medicare patients increasingly don't add up.

By Jeffrey Millstein


STAT+ | Dana-Farber CEO Laurie Glimcher has always been a trailblazer and a risk taker

How Laurie Glimcher ended up taking the greatest risk of her career: breaking up Dana Farber and Brigham & Women's Hospital.

By Shirley Leung


Molly Ferguson for STAT

STAT readers on teaching medical students about intellectual disabilities, sobering centers, and annual wellness visits

STAT readers on recent First Opinions on Medicare annual wellness visits, teaching future doctors about intellectual disabilities, and more.

By Torie Bosch


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments